Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1462 of 6351
-
Beyond the pelvis: could hip and leg alignment hold clues to stress incontinence?
Knowledge-focused Recruiting nowStress urinary incontinence (SUI) in postmenopausal women is traditionally considered a local pelvic floor disorder, but emerging evidence suggests that spinopelvic and lower limb alignment may also contribute to continence mechanisms. Transperineal ultrasound α/β angles and post…
Sponsor: Benha University • Aim: Knowledge-focused
Last updated Aug 07, 2026 00:00 UTC
-
New insulin pump system put to the test in 400-Person safety trial
Disease control OngoingThe purpose of this study is to check that a new insulin pump, called NMX8, is safe when used with a continuous glucose monitoring sensor called Disposable Sensor 5/Simplera Sync in people with diabetes. The study will include people with Type 1 diabetes who are 7-85 years old an…
Sponsor: Medtronic MiniMed, Inc. • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Common antibiotic could boost stroke recovery in major new trial
Disease control Recruiting nowThe goal of this study is to determine if Minocycline, when added to standard care, can improve survival and functional outcomes in patients with moderate acute stroke (ischemic or hemorrhagic) aged 18 years and older. The main questions it aims to answer are: 1. Does Minocycli…
Phase 2/3 • Sponsor: Joyce Chen • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New pill combo aims to ease stubborn shingles nerve pain
Symptom relief Recruiting nowThe goal of this clinical trial is to assess the efficacy and safety of Y-4 in patients with postherpetic neuralgia(PHN). The main questions it aims to answer are: The efficacy and safety of Y-4 to treat PHN compared with pregabalin. Researchers will analyze data from different…
Phase 2 • Sponsor: Neurodawn Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
New radiation boost aims to zap prostate tumors harder, faster
Disease control Recruiting nowThis study is for adult men with previously untreated high risk, very high risk, or pelvic lymph node positive prostate cancer. The purpose of this study is to evaluate the safety and effectiveness of the combination of two emerging radiation treatment techniques (hypofractionate…
Phase 2 • Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New biologic GR1803 aims to tame lupus in early trial
Disease control Recruiting nowto evaluate the safety and efficacy of GR1803 in the treatment of patients with systemic lupus erythematosus
Phase 1/2 • Sponsor: Genrix (Shanghai) Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Brazilian pilot program tests chikungunya Vaccine's Real-World power
Vaccine By invitation onlyThis is an observational, non-interventional, test-negative case-control (TNCC) study to estimate the vaccine effectiveness of VLA1553 against Chikungunya virus in a real-world setting.
Sponsor: Valneva Austria GmbH • Aim: Vaccine
Last updated Jul 19, 2026 00:00 UTC
-
New hope for muscle disease: drug trial launches
Disease control Not yet recruitingThe goal of this clinical trial is to evaluate the efficacy of Telitacicept in the treatment of inflammatory myopathy in patients with inflammatory diseases. The main question it aims to answer is: the safety and effectiveness of Telitacicept in treating inflammatory myopathy.
Phase 2/3 • Sponsor: Zhongming Qiu • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New pill for chronic hives tested in thousands of patients
Disease control Recruiting nowProspective, multi-country, non-interventional study in patients with CSU where the treatment decision prior enrolment has been made to either escalate current sgH1-AHs treatment or escalate/switch current treatment to remibrutinib. The primary aim of this study is to gather real…
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New injection shows promise for kidney disease patients
Disease control Not yet recruitingThis is a multicenter, open-label, proof-of-concept, phase Ⅱ adaptive basket clinical trial designed to evaluate the efficacy, safety, and pharmacokinetic profile of LP-005 Injection as add-on therapy to standard treatment in patients with complement-mediated renal diseases.
Phase 2 • Sponsor: Longbio Pharma • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New shot targets leukemia that chemo Can't beat
Disease control Not yet recruitingThis is an exploratory study with an open-label, single-arm, single-center design. It plans to enroll subjects with refractory/relapsed acute B-cell lymphoblastic leukemia (B-ALL), or treatment-naive or previously treated B-ALL subjects who achieved complete remission (CR) after …
Sponsor: Shanxi Bethune Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New drug aims to get sepsis patients off ventilators faster
Disease control Recruiting nowThe goal of this clinical trial is to learn if YD0743 works to treat sepsis-associated acute respiratory distress syndrome (ARDS) in adult patients admitted to the Intensive Care Unit. It will also learn about the safety of drug YD0743. The main questions it aims to answer are: …
Phase 2 • Sponsor: Shanghai Yidian Pharmaceutical Technology Development Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New hope for advanced lung cancer patients with no options left
Disease control Recruiting nowThe present study will explore a novel treatment strategy for unresectable lung adenocarcinoma combining a unique unconventional radiotherapy technique for high dose partial tumor irradiation (PTI) sparing the peritumoral immune microenvironment (PIM) with an immune checkpoint in…
Sponsor: Karl Landsteiner University of Health Sciences • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
New peptide injection could get athletes back in the game faster
Disease control Recruiting nowThis randomized, double-blind, placebo-controlled Phase 2 study evaluates whether pentadecapeptide BPC 157 (BPC-157), an investigational peptide, can speed structural healing and functional recovery after an acute grade II hamstring muscle strain. Participants will receive BPC 15…
Phase 2 • Sponsor: Hudson Biotech • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Could a mitochondrial peptide help reverse prediabetes?
Disease control Recruiting nowThis Phase 2a study evaluates whether 12 weeks of treatment with investigational MOTS-c improves insulin sensitivity compared with placebo in adults with prediabetes and overweight/obesity. Participants are randomized 1:1 to MOTS-c or placebo, receive standardized lifestyle coun…
Phase 2 • Sponsor: Hudson Biotech • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Can video Game-Style PE get kids moving more?
Disease control CompletedThis study evaluates the effects of an 8-week gamified cooperative exergaming program implemented during regular physical education lessons in primary school children. Participants were assigned by classroom to either an experimental group, which completed "The Movement League" p…
Sponsor: University of Jaén • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Can we predict endometriosis recurrence and fertility outcomes?
Knowledge-focused Recruiting nowEndometriosis is a chronic condition that may cause pelvic pain, ovarian cysts, infertility, and recurrent symptoms. This prospective observational cohort study will enroll women aged 18 to 45 years with endometriosis and age- and body mass index-matched healthy women. Participan…
Sponsor: Li Li • Aim: Knowledge-focused
Last updated Aug 08, 2026 00:03 UTC
-
Can training be timed to a Woman's cycle? a new study investigates
Knowledge-focused CompletedThis study aims to investigate the biochemical, hormonal, and physiological adaptations to a 10-week periodized high-intensity interval training (HIIT) programme in elite female futsal players. The study will examine changes in aerobic fitness, blood lactate kinetics, muscle dama…
Sponsor: Soran University • Aim: Knowledge-focused
Last updated Aug 22, 2026 00:00 UTC
-
New hope for teens with painful skin condition: experimental drug povorcitinib under study
Disease control Recruiting nowThe purpose of this study is to evaluate the pharmacokinetics, safety, and efficacy of povorcitinib in adolescent participants with moderate to severe hidradenitis suppurativa over a 54-week open-label treatment period.
Phase 2 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Can a new gel outsmart stubborn acne?
Disease control CompletedDouble blinded, randomized, placebo-controlled trial to determine the safety and efficacy of topical AT-004 therapy in participants with acne vulgaris, including assessment of reduction in the number of acne lesions and IGA. A PK sub-study will be performed in a subset of partici…
Phase 2 • Sponsor: Arctic Therapeutics • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC